Skip to content
Tenfell
Awarded contract
Published 17 Aug 2018

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders

Commercial Medicines Unit · United Kingdom

Key facts

Contract value
£41,000,000
Awarded
02 Jun 2016
Contract starts
31 Aug 2016
Contract ends
31 Aug 2017
Procedure
Competitive procedure with negotiation (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
Please refer to the document "Parties appointed to the framework£41,000,000

Description

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities.

Additional information: The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities.

Categories (CPV)

Similar open tenders

About Commercial Medicines Unit

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.